🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

Alosetron

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Alosetron, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

rilpivirine
2 shared targets
aplysinopsin
2 shared targets
Encainide
2 shared targets
irdabisant
2 shared targets
mosapride
3 shared targets
azelastine
2 shared targets
l
2 shared targets
pyrilamine
2 shared targets
1
2 shared targets
citalopram
2 shared targets
Loading evidence profile...

This evidence profile for Alosetron is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.